JP5847074B2 - 基板上対照検出 - Google Patents
基板上対照検出 Download PDFInfo
- Publication number
- JP5847074B2 JP5847074B2 JP2012505251A JP2012505251A JP5847074B2 JP 5847074 B2 JP5847074 B2 JP 5847074B2 JP 2012505251 A JP2012505251 A JP 2012505251A JP 2012505251 A JP2012505251 A JP 2012505251A JP 5847074 B2 JP5847074 B2 JP 5847074B2
- Authority
- JP
- Japan
- Prior art keywords
- control
- seconds
- reaction
- chamber
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000758 substrate Substances 0.000 title claims description 22
- 238000001514 detection method Methods 0.000 title description 7
- 238000012360 testing method Methods 0.000 claims description 175
- 238000006243 chemical reaction Methods 0.000 claims description 172
- 239000003153 chemical reaction reagent Substances 0.000 claims description 93
- 238000000034 method Methods 0.000 claims description 45
- 230000035899 viability Effects 0.000 claims description 43
- 230000004044 response Effects 0.000 claims description 27
- 238000007689 inspection Methods 0.000 claims description 21
- 230000003472 neutralizing effect Effects 0.000 claims description 20
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 230000003287 optical effect Effects 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 230000000704 physical effect Effects 0.000 claims description 8
- 230000006355 external stress Effects 0.000 claims description 7
- 230000028993 immune response Effects 0.000 claims description 7
- -1 N-oxide compound Chemical class 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 238000009792 diffusion process Methods 0.000 claims description 5
- 238000003487 electrochemical reaction Methods 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000000356 contaminant Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- ZYZQSCWSPFLAFM-UHFFFAOYSA-N 4-amino-2-chlorophenol Chemical compound NC1=CC=C(O)C(Cl)=C1 ZYZQSCWSPFLAFM-UHFFFAOYSA-N 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims 2
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000376 reactant Substances 0.000 description 33
- 239000000203 mixture Substances 0.000 description 29
- 238000005259 measurement Methods 0.000 description 16
- 239000004020 conductor Substances 0.000 description 15
- 125000006850 spacer group Chemical group 0.000 description 14
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 238000000835 electrochemical detection Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000003149 assay kit Methods 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000001010 compromised effect Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 150000001204 N-oxides Chemical class 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 150000002832 nitroso derivatives Chemical class 0.000 description 5
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000012254 powdered material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000003845 household chemical Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 238000012123 point-of-care testing Methods 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Ecology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Description
本願は、参照によりその全体が本願に組み込まれる、米国仮出願第61/170,440号明細書(2009年4月17日出願、発明の名称「電気化学的基板上対照検出(ELECTROCHEMICAL ON−BOARD CONTROL DETECTION)」)の優先権を主張する。
図1は、単一のチャンバを備える例示的な電気化学的バイオセンサの分解図を示す。1は下部電極を示し、2は絶縁分離器またはスペーサ層を示す。スペーサ層には、その長さの一部に沿って、開口部がある。3は上部電極を示す。上部電極3は、その長さの一部に沿う第1の開口部、および第1の開口部とある角度をなす第2の開口部を有する。上部電極の第1の開口部は、スペーサ層2の開口部と実質的に平行である。4は、5で示される充填チャンバのカバーを示す。6は反応チャンバを示す。充填チャンバ5は、下部電極1、カバー4、上部電極3の開口部、およびスペーサ層2の開口部によって、画定される。反応チャンバ6もまた、下部電極1、カバー4、上部電極3、上部電極3の開口部、およびスペーサ層2の開口部によって画定される。対照システムおよび検査システムは、反応チャンバ6内に配置することができる。
図2は、2つのチャンバを備える例示的な電気化学的バイオセンサの分解図を示す。1は下部電極を示し、2は絶縁分離器またはスペーサ層を示す。スペーサ層には、その長さの一部に沿って、開口部がある。3は上部電極を示す。上部電極3は、その長さの一部に沿う第1の開口部、第1の開口部とある角度をなす第2の開口部、および第1の開口部とある角度をなして第2の開口部と実質的に平行な第3の開口部を有する。上部電極の第1の開口部は、スペーサ層2の開口部と実質的に平行である。4は、5で示される充填チャンバのカバーを示す。6は反応チャンバを示す。充填チャンバ5は、下部電極1、カバー4、上部電極3の開口部、およびスペーサ層2の開口部によって画定される。2つの反応チャンバ6もまた、下部電極1、カバー4、上部電極3、上部電極3の開口部、およびスペーサ層2の開口部によって画定される。2つの反応チャンバの間に試料の通路がある。対照システムおよび検査システムは、異なる反応チャンバ6内に配置することができる。
図3は、例示的な電気化学的バイオセンサを示す。1は下部電極を示し、絶縁分離器すなわちスペーサ層は同図には示されていない。3は上部電極を示す。4は、5で示される充填チャンバのカバーを示す。6は反応チャンバを示す。対照システムおよび検査システムは、反応チャンバ6内に配置することができる。
図4は、異なる保管条件の後の凝固バイオセンサを使用した測定の比較を示す。電流記録は、正常血液がバイオセンサに添加されたときに開始した。最初の約3秒間は、外部電圧はバイオセンサに印加されなかった。バイオセンサ自体によって生成された電流が測定された。約3秒後、定電位電解装置はバイオセンサに約0.3Vを印加し、その結果生じた電流を測定した。菱形で印を付けられた点は、試料が所定のアルゴリズムにしたがって凝固したと見なされる時間を表す。太い実線は、室温で保管された2つのバイオセンサを表す。細い点線は、約60℃で2週間保管された2つのバイオセンサを表す。
Claims (31)
- 試料を評価するためのセンサであって、基板上対照システムおよび検査システムを含んでおり、前記対照システムが、ヨウ素、アスコルビン酸、フェリシアン化物、フェロシアン化物、4−アミノ−2−クロロフェノール、またはこれらのいずれかの組合わせから選択される少なくとも1つの対照試薬を含み、前記少なくとも1つの対照試薬がN−オキシド化合物ではなく、かつニトロソ官能基を含まず、かつ前記対照システムが前記対照試薬に関わる対照反応を含み、前記対照反応が対照信号を生成し、前記対照信号が前記対照システムおよび前記検査システムのうちの少なくとも1つの生存能を示し、前記対照反応で用いられた前記対照試薬は前記検査システムの反応に対しては使用可能ではない、センサ。
- 前記対照システムが電気化学的対照システムを含む、請求項1に記載のセンサ。
- 前記対照反応が外部電圧を用いることなく評価される、請求項2に記載のセンサ。
- 前記対照反応が、前記少なくとも1つの試薬を試料と接触させると活性化され、前記接触が前記対照信号の生成を開始する、請求項1に記載のセンサ。
- 前記生成された対照信号が外部ストレスに依存し、前記外部ストレスが、温度、pH、湿度、酸素、光、保管寿命、事前の液体接触、および化学汚染物質から選択される少なくとも1つを含む、請求項4に記載のセンサ。
- 前記対照システムが少なくとも2つの電極を含み、前記少なくとも1つの試薬が前記電極のうちの少なくとも1つに被覆され、前記少なくとも2つの電極が同一平面内にある、または互いに対向している、請求項2に記載のセンサ。
- 前記対照反応が起電力を発生させる、請求項2に記載のセンサ。
- 前記起電力が、前記少なくとも1つの試薬の前記試料中への溶解をもとに発生される、請求項7に記載のセンサ。
- 前記少なくとも1つの試薬がフェリシアン化物を含む、請求項2に記載のセンサ。
- 前記対照システムが少なくとも2つの電極を含み、前記電極のうちの少なくとも1つに被覆されたフェリシアン化物の面積負荷が、1平方メートル当たり10×10−6から200×10−6モルである、請求項9に記載のセンサ。
- 前記少なくとも1つの試薬が中和剤を含み、前記中和剤が中和作用によって前記対照信号を中和する、請求項1に記載のセンサ。
- 前記中和作用が、化学反応および物理的効果から選択される少なくとも1つを含む、請求項11に記載のセンサ。
- 前記物理的効果が、沈殿および拡散から選択される少なくとも1つを含む、請求項12に記載のセンサ。
- 前記対照システムおよび前記検査システムが1つのチャンバ内に配置されている、または、前記対照システムが第1のチャンバ内に配置され、前記検査システムの少なくとも一部が第2のチャンバ内に配置されている、請求項1に記載のセンサ。
- 前記第1のチャンバおよび前記第2のチャンバが並列に流体接続または試料通路を介して直列に流体接続している、請求項14に記載のセンサ。
- センサを使用して試料を評価する方法であって、
基板上対照システムおよび検査システムを含む前記センサに前記試料を付着させることであって、前記対照システムが、ヨウ素、アスコルビン酸、フェリシアン化物、フェロシアン化物、4−アミノ−2−クロロフェノール、またはこれらのいずれかの組合わせから選択される少なくとも1つの対照試薬を含み、前記少なくとも1つの対照試薬がN−オキシド化合物ではなく、かつニトロソ官能基を含まず、かつ前記対照システムが前記対照試薬に関わる対照反応を含み、前記対照反応が対照信号を生成し、前記対照信号が前記対照システムおよび前記検査システムのうちの少なくとも1つの生存能を示し、前記対照反応で用いられた前記対照試薬は前記検査システムの反応に対しては使用可能ではない、付着させることと、
前記対照システムおよび前記検査システムのうちの少なくとも1つの生存能を判定するために、前記対照信号を標準信号と比較することと
を含む方法。 - 前記検査システム内の前記試料を評価することをさらに含む、請求項16に記載の方法。
- 前記対照システムは、電気化学的対照システムを含む、請求項16に記載の方法。
- 前記対照反応は、外部電圧を用いることなく評価される、請求項18に記載の方法。
- 前記対照反応は、前記少なくとも1つの試薬を試料と接触させると活性化され、前記接触は前記対照信号の生成を開始する、請求項16に記載の方法。
- 前記対照システムは、少なくとも2つの電極を含むとともに前記少なくとも1つの試薬は前記電極のうちの少なくとも1つに被覆され、前記少なくとも2つの電極が同一平面内にある、または互いに対向している、請求項18に記載の方法。
- 前記対照反応は、起電力を発生させる、請求項18に記載の方法。
- 前記起電力は、前記少なくとも1つの試薬の前記試料中への溶解をもとに発生される、請求項22に記載の方法。
- 前記少なくとも1つの試薬は、フェリシアン化物を含む、請求項18に記載の方法。
- 前記少なくとも1つの試薬は、中和剤を含むとともに前記中和剤は中和作用によって前記対照信号を中和する、請求項16に記載の方法。
- 前記中和作用は、化学反応および物理的効果から選択される少なくとも1つを含む、請求項25に記載の方法。
- 前記対照システムおよび前記検査システムは、1つのチャンバ内に配置されている、または、前記対照システムが第1のチャンバ内に配置され、前記検査システムの少なくとも一部が第2のチャンバ内に配置されている、請求項16に記載の方法。
- 前記第1のチャンバおよび前記第2のチャンバは、並列に流体接続または試料通路を介して直列に流体接続している、請求項27に記載の方法。
- 前記試料を前記第1のチャンバから前記第2のチャンバへ毛細管現象により移送するステップをさらに含む、請求項28に記載の方法。
- 前記検査システム内の前記試料を評価することは、免疫反応および電気化学反応から選択される少なくとも1つの反応を測定することを含む、請求項17に記載の方法。
- 前記検査システム内の前記試料を評価することは、電気信号および光信号から選択される少なくとも1つの検査信号を測定することを含む、請求項17に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17044009P | 2009-04-17 | 2009-04-17 | |
US61/170,440 | 2009-04-17 | ||
PCT/IB2010/000972 WO2010119341A1 (en) | 2009-04-17 | 2010-04-16 | On-board control detection |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012524254A JP2012524254A (ja) | 2012-10-11 |
JP2012524254A5 JP2012524254A5 (ja) | 2015-08-06 |
JP5847074B2 true JP5847074B2 (ja) | 2016-01-20 |
Family
ID=42982153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012505251A Active JP5847074B2 (ja) | 2009-04-17 | 2010-04-16 | 基板上対照検出 |
Country Status (14)
Country | Link |
---|---|
US (1) | US9863931B2 (ja) |
EP (1) | EP2419725A4 (ja) |
JP (1) | JP5847074B2 (ja) |
KR (1) | KR101881597B1 (ja) |
CN (2) | CN102395880A (ja) |
AU (2) | AU2010238253A1 (ja) |
BR (1) | BRPI1016110B1 (ja) |
CA (1) | CA2759065C (ja) |
IL (1) | IL215791B (ja) |
MX (1) | MX2011010823A (ja) |
SG (2) | SG10201400971TA (ja) |
TW (1) | TWI570408B (ja) |
WO (1) | WO2010119341A1 (ja) |
ZA (1) | ZA201107816B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201400971TA (en) | 2009-04-17 | 2014-07-30 | Universal Biosensors Pty Ltd | On-board control detection |
US8956518B2 (en) | 2011-04-20 | 2015-02-17 | Lifescan, Inc. | Electrochemical sensors with carrier field |
US9551699B2 (en) * | 2012-07-16 | 2017-01-24 | Micropoint Bioscience, Inc. | Testing of blood coagulation characteristics |
US20220032288A1 (en) * | 2020-07-29 | 2022-02-03 | Smart Ink Technology Corp. | Viral and biochemical early detection test kits |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4426451A (en) * | 1981-01-28 | 1984-01-17 | Eastman Kodak Company | Multi-zoned reaction vessel having pressure-actuatable control means between zones |
BR9607193B1 (pt) | 1995-03-10 | 2009-01-13 | teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos. | |
DE19831519C2 (de) * | 1998-07-14 | 2002-01-17 | Roche Diagnostics Gmbh | Analyseelement-Packungseinheit |
EP1151268B1 (en) | 1998-07-29 | 2004-12-22 | Hemosense, Inc. | Method and device for measuring blood coagulation or lysis by viscosity changes |
US6716577B1 (en) | 2000-02-02 | 2004-04-06 | Lifescan, Inc. | Electrochemical test strip for use in analyte determination |
CN1432130A (zh) * | 2000-03-08 | 2003-07-23 | 糖尿病诊断公司 | 快速响应葡萄糖传感器 |
WO2001073124A2 (en) * | 2000-03-28 | 2001-10-04 | Diabetes Diagnostics, Inc. | Rapid response glucose sensor |
US20020092612A1 (en) * | 2000-03-28 | 2002-07-18 | Davies Oliver William Hardwicke | Rapid response glucose sensor |
AU7319701A (en) | 2000-07-14 | 2002-01-30 | Usf Filtration & Separations | Electrochemical method for measuring chemical reaction rates |
JP4639465B2 (ja) * | 2000-11-30 | 2011-02-23 | パナソニック株式会社 | バイオセンサ |
AU2002349656A1 (en) * | 2001-11-20 | 2003-06-10 | Arkray, Inc. | Fail judging method and analyzer |
US6872299B2 (en) * | 2001-12-10 | 2005-03-29 | Lifescan, Inc. | Passive sample detection to initiate timing of an assay |
US20060134713A1 (en) * | 2002-03-21 | 2006-06-22 | Lifescan, Inc. | Biosensor apparatus and methods of use |
US20030180814A1 (en) * | 2002-03-21 | 2003-09-25 | Alastair Hodges | Direct immunosensor assay |
US6964871B2 (en) * | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
CA2392980A1 (en) * | 2002-07-11 | 2004-01-11 | Lifescan, Inc. | Electrochemical test strip having a plurality of reaction chambers and methods for using the same |
CN1469117A (zh) * | 2002-07-18 | 2004-01-21 | 生命扫描有限公司 | 有多个反应腔室的电化学测试条及其使用方法 |
EP1577665B1 (en) | 2002-12-20 | 2013-06-26 | ARKRAY, Inc. | Thin analyzing test strip |
EP1656554B1 (en) * | 2003-08-21 | 2018-11-07 | AgaMatrix, Inc. | Method and apparatus for assay of electrochemical properties |
DE10346863A1 (de) | 2003-10-09 | 2005-05-04 | Roche Diagnostics Gmbh | On-Board-Kontrolle für Analyseelemente |
CN1834637A (zh) * | 2005-03-16 | 2006-09-20 | 商洲生技有限公司 | 电子传感器之检测方法 |
US8192599B2 (en) | 2005-05-25 | 2012-06-05 | Universal Biosensors Pty Ltd | Method and apparatus for electrochemical analysis |
US8323464B2 (en) | 2005-05-25 | 2012-12-04 | Universal Biosensors Pty Ltd | Method and apparatus for electrochemical analysis |
TWM297470U (en) * | 2006-02-21 | 2006-09-11 | Visgeneer Inc | Structures of biosensor strips |
ES2389382T3 (es) | 2006-02-21 | 2012-10-25 | Universal Biosensors Pty Limited | Mecanismo de transferencia de fluidos |
SI2047253T1 (sl) | 2006-07-17 | 2016-04-29 | Universal Biosensors Pty Limited | Elektrokemično zaznavanje mobilnosti magnetnih delcev |
GB0621352D0 (en) | 2006-10-27 | 2006-12-06 | Suresensors | Measurement device |
US20080199894A1 (en) * | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
TWI516601B (zh) * | 2007-10-26 | 2016-01-11 | 環球生物醫療感測器私人有限公司 | 電化學檢測之裝置及方法 |
JP5769620B2 (ja) | 2008-07-11 | 2015-08-26 | ユニバーサル バイオセンサーズ ピーティーワイ リミテッドUniversal Biosensors Pty Limited | 改良型免疫測定センサ |
SG10201400971TA (en) | 2009-04-17 | 2014-07-30 | Universal Biosensors Pty Ltd | On-board control detection |
-
2010
- 2010-04-16 SG SG10201400971TA patent/SG10201400971TA/en unknown
- 2010-04-16 SG SG2011074374A patent/SG175190A1/en unknown
- 2010-04-16 KR KR1020117027258A patent/KR101881597B1/ko active IP Right Grant
- 2010-04-16 CN CN201080016852XA patent/CN102395880A/zh active Pending
- 2010-04-16 JP JP2012505251A patent/JP5847074B2/ja active Active
- 2010-04-16 TW TW099112002A patent/TWI570408B/zh active
- 2010-04-16 WO PCT/IB2010/000972 patent/WO2010119341A1/en active Application Filing
- 2010-04-16 BR BRPI1016110-4A patent/BRPI1016110B1/pt active IP Right Grant
- 2010-04-16 US US13/264,926 patent/US9863931B2/en active Active
- 2010-04-16 MX MX2011010823A patent/MX2011010823A/es active IP Right Grant
- 2010-04-16 CN CN202110344352.9A patent/CN113092562B/zh active Active
- 2010-04-16 CA CA2759065A patent/CA2759065C/en active Active
- 2010-04-16 AU AU2010238253A patent/AU2010238253A1/en not_active Abandoned
- 2010-04-16 EP EP10764162.3A patent/EP2419725A4/en not_active Ceased
-
2011
- 2011-10-23 IL IL215791A patent/IL215791B/en active IP Right Grant
- 2011-10-26 ZA ZA2011/07816A patent/ZA201107816B/en unknown
-
2016
- 2016-02-29 AU AU2016201281A patent/AU2016201281B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI1016110B1 (pt) | 2019-11-12 |
JP2012524254A (ja) | 2012-10-11 |
CN113092562B (zh) | 2024-03-29 |
KR101881597B1 (ko) | 2018-07-24 |
WO2010119341A1 (en) | 2010-10-21 |
CA2759065C (en) | 2019-01-15 |
CA2759065A1 (en) | 2010-10-21 |
ZA201107816B (en) | 2012-07-25 |
AU2010238253A1 (en) | 2011-11-24 |
EP2419725A4 (en) | 2014-11-26 |
TWI570408B (zh) | 2017-02-11 |
BRPI1016110A2 (pt) | 2016-08-23 |
IL215791A0 (en) | 2012-01-31 |
MX2011010823A (es) | 2011-12-06 |
CN113092562A (zh) | 2021-07-09 |
IL215791B (en) | 2018-02-28 |
SG175190A1 (en) | 2011-12-29 |
US9863931B2 (en) | 2018-01-09 |
CN102395880A (zh) | 2012-03-28 |
SG10201400971TA (en) | 2014-07-30 |
AU2016201281B2 (en) | 2018-02-01 |
EP2419725A1 (en) | 2012-02-22 |
TW201111779A (en) | 2011-04-01 |
KR20120017428A (ko) | 2012-02-28 |
AU2016201281A1 (en) | 2016-03-17 |
US20120040369A1 (en) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU778966B2 (en) | Electrochemical test strip for use in analyte determination | |
KR101854883B1 (ko) | 전기화학적 검출용의 장치 및 방법 | |
KR100828450B1 (ko) | 면역센서 | |
JP4879459B2 (ja) | 液体サンプルの分析のための電気化学式バイオセンサストリップ | |
TWI516288B (zh) | 用於免疫感測器之黏著組成物 | |
JP6646579B2 (ja) | 高アンモニア血症の検出のためのデバイス及びデバイスを使用する方法 | |
TW201037299A (en) | System and methods for determination of analyte concentration using time resolved amperometry | |
CZ20022733A3 (cs) | Elektrochemický koagulační test a zařízení pro jeho provádění | |
RU2007117732A (ru) | Определение концентрации в диффузионном барьерном слое | |
TWI481867B (zh) | 與具有相對電極之雙腔室多分析物測試條併用的測試計 | |
JP6397822B2 (ja) | デバイスおよびアミノアシドパシーの検出のためにデバイスを用いる方法 | |
JP5847074B2 (ja) | 基板上対照検出 | |
CN112638532B (zh) | 具有用于减轻流体样本漂移的旁路通道的盒装置 | |
TW201346255A (zh) | 具有配置填充速度之試劑層之基於電化學的分析試驗帶 | |
JP2015535683A (ja) | 酵素検出のためのシステム及び方法 | |
JP4996599B2 (ja) | クレアチニンセンサーを二価マンガンイオン溶液で安定化または再活性化する方法 | |
Rahman et al. | Selective choline biosensors based on choline oxidase co-immobilized into self-assembled monolayers on micro-chips at low potential | |
JP2016505153A (ja) | 可溶性酸性材料コーティングを備える電気化学式分析試験用ストリップ | |
Raz et al. | Transdermal Minimally-Invasive Optical Multiplex Detection of Protein Biomarkers by Microneedles-Embedded Nanopillars Array | |
JP2009276276A (ja) | 測定デバイス及びそれを用いた測定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130416 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130416 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140114 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140414 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140421 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140507 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141216 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150313 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20150616 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151027 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151124 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5847074 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |